Ironwood Pharmaceuticals, Inc. (IRWD)

Ironwood Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 30, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	795	709	1,786	1,901	1,908	1,824
Market Cap Growth	32.92%	-60.31%	-6.02%	-0.40%	4.64%	-12.64%
Enterprise Value	1,253	1,236	2,414	1,742	1,804	1,964
Last Close Price	4.89	4.43	11.44	12.39	11.66	11.39
PE Ratio	27.61	805.60	-	10.86	3.61	17.17
Forward PE	6.52	13.42	14.14	11.24	8.43	10.89
PS Ratio	2.33	2.02	4.03	4.63	4.61	4.68
PB Ratio	-	-2.35	-5.16	2.91	3.15	29.11
P/TBV Ratio	-	-	-	2.91	3.15	29.11
P/FCF Ratio	11.76	6.86	9.75	6.95	7.29	10.92
P/OCF Ratio	11.75	6.85	9.74	6.94	7.29	10.80
PEG Ratio	-	-	1.98	2.25	1.21	1.09
EV/Sales Ratio	3.70	3.52	5.45	4.24	4.36	5.04
EV/EBITDA Ratio	8.60	12.64	12.23	6.92	7.72	12.23
EV/EBIT Ratio	8.72	12.91	12.33	6.96	7.77	12.41
EV/FCF Ratio	18.53	11.95	13.18	6.37	6.90	11.76
Debt / Equity Ratio	-2.26	-1.99	-2.07	0.64	0.79	7.24
Debt / EBITDA Ratio	4.02	5.89	3.56	1.63	2.01	2.76
Debt / FCF Ratio	8.84	5.80	3.91	1.52	1.82	2.72
Asset Turnover	0.86	0.86	0.56	0.37	0.49	0.81
Quick Ratio	1.08	4.39	0.80	30.23	4.54	15.07
Current Ratio	1.13	4.70	0.85	30.58	4.61	15.41
Return on Equity (ROE)	-	-	-674.04%	27.83%	158.09%	-
Return on Assets (ROA)	22.88%	14.56%	15.58%	14.05%	17.21%	20.57%
Return on Invested Capital (ROIC)	22.42%	0.53%	56.83%	39.75%	75.47%	98.13%
Return on Capital Employed (ROCE)	93.60%	30.70%	100.40%	23.30%	24.10%	30.00%
Earnings Yield	3.59%	0.12%	-56.11%	9.21%	27.69%	5.82%
FCF Yield	8.50%	14.59%	10.25%	14.40%	13.71%	9.16%
Buyback Yield / Dilution	-9.90%	-2.99%	16.57%	-13.32%	-2.34%	-2.97%

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q